The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and New Cyber Security Contract Win

11 May 2016 07:00

RNS Number : 8828X
Falanx Group Limited
11 May 2016
 

11 May 2016

 

FALANX GROUP LIMITED

("Falanx", "the Group" or "the Company")

 

Trading Update

and

New Cyber Security Contract Win

 

Falanx Group Limited, a cyber defence and intelligence provider working with blue chip and government clients worldwide, is pleased to provide the following pre-close trading update.

 

The Company is trading in line with management's expectations. As a result of recent UK Government cyber contract wins, a growing client base, and its recent fundraising, net cash is now at £1.5m post costs of acquiring ASC. Falanx has also carefully managed its costs downward and has a reducing burn rate of circa £100k per month. 

 

Falanx believes it now has the foundations in place to advance its strategy having reorganised the Group to deliver a comprehensive suite of cyber security services, appointed Mike Read as non-executive Chairman, and having acquired Advanced Security Consulting Limited (ASC). Its highly regarded Business Intelligence division continues to demonstrate profitable growth and remains a valuable business development platform with over 70 blue chip clients.

 

New Cyber Security Contract Win

 

The Health Foundation has selected and contracted the managed Cyber Security Services of Falanx Cyber. The core networks of the Foundation will be protected in order to ensure privacy of data and network assurance. This is the first contract to be won using the consultancy process of ASC to deliver prepared client networks for continued long-term protection from our Security Operations Centre. Securing this contract also allows us to prove the application of our services outside of Government and into the Health and Charity markets.

 

Group Enlargement

 

In March 2015, Falanx informed shareholders of its intention to shift strategic focus to enlarge and develop its cyber security capacity. This decision was taken in response to the increasing importance Governments and blue chip organisations are placing on this issue. The financial cost that can result from data theft and the damage to reputations caused by losing customer information can have a catastrophic impact. A number of high profile cyber-attacks toward the end of 2015 brought the need for rigorous security and risk management into sharp focus. As a result, many organisations have placed cyber security at the top of their priority list for 2016. This has in turn helped cement the market opportunity for Falanx, with companies and Government bodies assessing the precise nature of the threats they face and identifying their vulnerabilities.

 

Falanx has now completed the reorganisation required to take advantage of this market opportunity. This reorganisation started with the launch of its Security Operations Centre (SOC) in Reading in March 2015, designed specifically to secure computer networks at the boundary and across the devices within. The SOC allows Falanx to manage and analyse data, whilst also providing helpdesk services to continuously protect both legacy and cloud computing systems from hostile attacks, unauthorised data access and theft. The Company achieved ISO 9001, /IEC 20000-1 and ISO/IEC 27001 accreditation, enabling Falanx to pursue major contracts with UK Government agencies, regulators and multi-nationals, and invested in its sales and marketing team. Falanx Intelligence and Resilience divisions are now enabled to market Falanx's cyber security solution to their existing network of blue chip and government clients.

 

Appointment of Mike Read as Non-Executive Chairman

 

Falanx Group announced the appointment of Mike Read on 2 February 2016. Mike has over 30 years' experience in the global Telecommunications, Media and Technology (TMT) sector and has been a director of eight public companies. He has held numerous 'C' level roles in the UK and USA, including CEO of Pipex Communications, Executive Director at Daisy Group Plc, Non-Executive Director at Nasstar Plc, and Non-Executive Chairman at IntY Ltd. 

 

Mike has significant experience helping to build international technology companies, having been involved on over 50 M&A transactions. He also has numerous relationships with the senior management teams of blue chip organisations, and has already helped to introduce Falanx to new business opportunities.

 

Acquisition of ASC

 

Falanx Group announced the acquisition of ASC on 5 May 2016. ASC is a market leading cyber security services organisation offering consulting, managed services, penetration testing and training. The organisation utilises senior trusted advisors and true industry experts with over 18 years of experience covering multiple sectors including financial services, pharmaceuticals and healthcare. ASC was founded in 2012 by Jay Abbott, its Managing Director and sole shareholder. Mr Abbott previously led the UK National Threat & Vulnerability Management Practice of PriceWaterhouseCoopers. Jay is also the chair of the Competitions Board for the UK Cyber Security Challenge and a member of the Defence and Security Board of TechUK. He will now become Managing Director of the Falanx Cyber Division, driving commercial market penetration, the technology roadmap and innovation.

 

ASC's capabilities are entirely complementary to Falanx and will allow the Group to offer a compelling and integrated cyber security solution to organisations of all types, delivered by highly qualified experts. The acquisition will help Falanx to offer new services to existing blue-chip Falanx Intelligence clients and to a wider range of businesses.

 

John Blamire, CEO of Falanx, said:

 

"Falanx continues to build a growing pipeline and is in contract negotiations with a number of further prospects, though the lead time for securing large corporate and Government sales can be significant. With any industry which is evolving rapidly it will take time for organisations and Government departments to properly assess the precise nature of the threat and identify their vulnerabilities. The key is to have in place the correct infrastructure, a skilled team, accreditations and an established reputation of working successfully with major Government bodies. Having these building blocks in place will position Falanx as a provider of choice to organisations as they start to properly understand and define the cyber defence services that they require."

 

Enquiries:

 

Falanx Group Limited

John Blamire, Chief Executive

www.falanxgroup.com

www.falanxassuria.com

+ 44 (0) 20 7856 9457 

 

 

Panmure Gordon (UK) Limited

Nominated Adviser & Broker

+44 (0) 20 7886 2500

Andrew Godber

 

 

 

Redleaf Communications

Charlie Geller

Susie Hudson

 

Notes to Editors

 

+44 (0) 20 7382 4730 

falanx@redleafpr.com 

Falanx Group Limited, is a global intelligence, security and cyber defence provider working with blue chip and government clients.

 

The Group listed on AIM in June 2013 under ticker FLX

 

For more information: http://www.falanxgroup.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTABMATMBIBMRF
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.